AAAAAA

   
Results: 1-3 |
Results: 3
Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand
Authors: Nsimba, SED Aden-Abdi, Y Rimoy, G Massele, AY Alm, C Ericsson, O Gustafsson, LL
Citation: Sed. Nsimba et al., Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand, J CLIN PH T, 26(1), 2001, pp. 43-48
Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype
Authors: Herrlin, K Massele, AY Rimoy, G Alm, C Rais, M Ericsson, O Bertilsson, L Gustafsson, LL
Citation: K. Herrlin et al., Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype, CLIN PHARM, 68(2), 2000, pp. 189-198
Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype
Authors: Wennerholm, A Johansson, I Massele, AY Jande, M Alm, C Aden-Abdi, Y Dahl, ML Ingelman-Sundberg, M Bertilsson, L Gustafsson, LL
Citation: A. Wennerholm et al., Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype, PHARMACOGEN, 9(6), 1999, pp. 707-714
Risultati: 1-3 |